IthaID: 3275

Names and Sequences

Functionality:	Globin gene causative mutation	Pathogenicity:	N/A
Common Name:	(αα)ALT	HGVS Name:	N/A
Hb Name:	N/A	Protein Info:	N/A

Also known as:

Comments: The deletion removes only the the major α-globin regulatory element MCS-R2 (HS-40 site). The deletion extends from position chromosome 16g.103,193 to 106,553 removing 3361 bp. In addition, an insertion of 39 bp bridging the deletion breakpoints was observed possibly resulting from a complex rearrangement involving two fragments of DNA from chromosome 3.

External Links

No available links

Phenotype

Hemoglobinopathy Group:	Thalassaemia
Hemoglobinopathy Subgroup:	α-thalassaemia
Allele Phenotype:	N/A
Associated Phenotypes:	N/A

IthaPhen

Heterozygous records (preview in IthaPhen)

Location

Chromosome:	16
Locus:	NG_000006.1
Locus Location:	N/A
Size:	3.361 kb
Deletion involves:	HS40

Other details

Type of Mutation:	Deletion
Ethnic Origin:	Portuguese
Molecular mechanism:	N/A
Inheritance:	Recessive
DNA Breakpoint Determined:	Yes

Sequence Viewer

Note: The NCBI Sequence Viewer is not installed on the ITHANET servers but it is embedded in this page from the NCBI. Therefore, IthaGenes has no responsibility over any temporary unavailability of the service. In such a case, please Refresh the page or retry at a later stage. Otherwise, use this external link.

Publications / Origin

Ferrão J, Silva M, Gonçalves L, Gomes S, Loureiro P, Coelho A, Miranda A, Seuanes F, Reis AB, Pina F, Maia R, Kjöllerström P, Monteiro E, Lacerda JF, Lavinha J, Gonçalves J, Faustino P, Widening the spectrum of deletions and molecular mechanisms underlying alpha-thalassemia., Ann. Hematol. , 96(11), 1921-1929, 2017 PubMed

Created on 2017-11-08 20:29:58, Last reviewed on (Show full history)

A/A	Date	Curator(s)	Comments
1	2017-11-08 20:29:58	The IthaGenes Curation Team	Created

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.